Literature DB >> 1732410

Interleukin 3 is a growth factor for human follicular B cell lymphoma.

C Clayberger1, S Luna-Fineman, J E Lee, A Pillai, M Campbell, R Levy, A M Krensky.   

Abstract

More than one-half of adults with non-Hodgkin's B cell lymphomas present with low-grade follicular lymphomas. These tumor cells are found in close association with follicular T lymphocytes and dendritic cells, suggesting that the surrounding cells may play a role in the support of follicular tumors. Supernatants from activated human peripheral blood lymphocytes were found to promote the in vitro proliferation of follicular tumor cells. This effect was entirely due to interleukin 3 (IL-3), a factor generally thought to cause the growth and differentiation of immature hematopoietic cells. IL-3 receptors were detected on fresh isolates of all primary follicular cell tumors examined. These findings suggest that follicular cell tumors may be dependent in vivo on IL-3 and that therapies directed against IL-3, its receptor, or the T cells that produce it may be effective treatment for follicular lymphoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732410      PMCID: PMC2119105          DOI: 10.1084/jem.175.2.371

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  Regulation of human B-cell ontogeny.

Authors:  F M Uckun
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

Review 2.  T lymphocyte-derived colony-stimulating factors.

Authors:  A Kelso; D Metcalf
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

3.  Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

Authors:  A Ganser; A Lindemann; G Seipelt; O G Ottmann; F Herrmann; M Eder; J Frisch; G Schulz; R Mertelsmann; D Hoelzer
Journal:  Blood       Date:  1990-08-15       Impact factor: 22.113

4.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

Authors:  M L Cleary; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

5.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

6.  Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

Authors:  M E Rothenberg; W F Owen; D S Silberstein; J Woods; R J Soberman; K F Austen; R L Stevens
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

7.  Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.

Authors:  K Thielemans; D G Maloney; T Meeker; J Fujimoto; C Doss; R A Warnke; J Bindl; J Gralow; R A Miller; R Levy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.

Authors:  J W Mier; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells.

Authors:  S J Korsmeyer; P A Hieter; J V Ravetch; D G Poplack; T A Waldmann; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  The monoclonality of human B-cell lymphomas.

Authors:  R Levy; R Warnke; R F Dorfman; J Haimovich
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more
  9 in total

Review 1.  A primer on cytokines: sources, receptors, effects, and inducers.

Authors:  J H Curfs; J F Meis; J A Hoogkamp-Korstanje
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 2.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

Authors:  J L Ambrus; J Pippin; A Joseph; C Xu; D Blumenthal; A Tamayo; K Claypool; D McCourt; A Srikiatchatochorn; R J Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 4.  The follicular lymphoma microenvironment: From tumor cell to host immunity.

Authors:  Antonio Martinez; Joaquim Carreras; Elias Campo
Journal:  Curr Hematol Malig Rep       Date:  2008-10       Impact factor: 3.952

5.  Expression of mouse mammary tumor virus superantigen accelerates tumorigenicity of myeloma cells.

Authors:  M Umemura; W Wajjwalku; N Upragarin; T Liu; H Nishimura; T Matsuguchi; Y Nishiyama; G M Wilson; Y Yoshikai
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

Authors:  Donatella Aldinucci; Dalisa Poletto; Annunziata Gloghini; Paola Nanni; Massimo Degan; Tiziana Perin; Paola Ceolin; Francesca Maria Rossi; Valter Gattei; Antonino Carbone; Antonio Pinto
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 8.  Cytotoxic T lymphocyte recognition of non-Hodgkin's B cell lymphomas.

Authors:  A M Krensky
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

9.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.